Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ©) for health-related quality of life assessment in chronic obstructive pulmonary disease

International Journal of COPD

Volumn 4, Issue 1, 2009, Pages 9-18

  Perez, T ^a   Arnould, Benoit ^b,e   Grosbois, J M ^c   Bosch, V ^b   Guillemin, I ^b   Bravo, M L ^d   Brun, M ^d   Tonnel, A B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b MAPI VALUES   (United States)

^c Centre Hospitalier de Bethune   (France)

^d BOEHRINGER INGELHEIM   (France)

^e NONE   (France)

Author keywords

Chronic obstructive pulmonary disease; Hea related quality of life; Minimal important difference; SGRQ; VSRQ

Indexed keywords

TIOTROPIUM BROMIDE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCURRENT VALIDITY; DYSPNEA; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; TEST RETEST RELIABILITY; VISUAL SIMPLIFIED RESPIRATORY QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; AGED; ANXIETY; CHOLINERGIC ANTAGONISTS; DEPRESSION; DYSPNEA; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESPIRATION; SCOPOLAMINE DERIVATIVES; SEVERITY OF ILLNESS INDEX; SEXUAL BEHAVIOR; SLEEP; SOCIAL BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME;

EID: 66149083241     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320:1297-1303.
2. Gay PC. Chronic obstructive pulmonary disease and sleep. Respir Care. 2004;49:39-51.
3. Janssens JP, Rochat T, Frey JG, Dousse N, Pichard C, Tschopp JM. Health-related quality of life in patients under long-term oxygen therapy: a home-based descriptive study. Respir Med. 1997;91:592-602.
4. Killian KJ. Limitation to muscular activity in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:6-7.
5. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax. 1996;51:44-47.
6. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003;22:1-2.
7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive summary. 2006. Cited Oct 6, 2008. Available from http://www.goldcopd.com 2006.
8. Lareau SC, Breslin EH, Meek PM. Functional status instruments: outcome measure in the evaluation of patients with chronic obstructive pulmonary disease. Heart Lung. 1996;25:212-224.
9. Hyland ME, BOTT J, Singh S, Kenyon CAP. Domains, constructs and the development of the Breathing Problems Questionnaire. Qual Life Res. 1994;3:245-256.
10. Hyland ME, Singh SJ, Sodergren SC, Morgan MPL. Development of a shortened version of the breathing problems questionnaire suitable for use in a pulmonary rehabilitation clinic: a purpose-specific, diseasespecific questionnaire. Qual Life Res. 1998;7:227-233.
11. Maille AR, Koning CJM, Zwinderman AH, Willems LNA, Dijkman JH, Kaptein AA. The development of the 'Quality-of-Life for Respiratory Illness Questionnaire (QOL-RIQ)': a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med. 1997;91:297-309.
12. Van Der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
13. Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med. 1991;85:25-31.
14. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321-1327.
15. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773-778.
16. Wijkstra PJ, Ten Vergert EM, Van Altena R, Otten V, Postma DS, Kraan J, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax. 1994;49:465-467.
17. Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic Respiratory disease Questionnaire (CRQ). COPD. 2005;2:81-89.
18. Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, et al. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:1874-1878.
19. Tonnel A-B, Perez T, Grosbois J-M, Verkindre C, Bravo M-L, Brun M. Effect of tiotropium on Health-Related Quality of Life as a primary efficacy endpoint in COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:301-310.
20. Grosbois J-M, Mulkowski C, Clabaut M, Duquesnoy B, Wattier I, Bart F. Intérêt des échelles visuelles analogiques dans l'évaluation de la qualité de vie des BPCO avant et après réhabilitation respiratoire. Rev Mal Respir. 2006;23:408.
21. Vapnik VN. Statistical learning theory. New York: Wiley-Interscience; 1998.
22. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patientreported outcomes: The example of health-related quality of life: A European guidance document for the improved integration of healthrelated quality of life assessment in the drug regulatory process. Drug Inf.J. 2002;36:209-238.
23. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res. 2002;11:195-203.
24. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill Inc; 1994.
25. Hays RD, Hayashi T. Beyond internal consistency reliability: rationale and user's guide for Multitrait analysis program on the microcomputer. Behav Res Methods Instrum Comput. 1990;22:167-175.
26. Hays RD, Anderson R, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Quality of Life assessment in clinical trials: methods and practice. Oxford: Oxford University Press; 1998. p. 169-182.
27. Cronbach LJ. Coefficient Alpha and the Internal Structure of Tests. Psychometrika. 1951;16:297-334.
28. Deyo RA, Diehr P, Patrick DL. Reproducibility and Responsiveness of Health Status Measures. Statistics and Strategies for Evaluation. Control Clin Trials. 1991;142-158.
29. Hays RD, Revicki DA, Anderson R. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res. 1993;2:441-449.
30. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurements a clarification. J Clin Epidemiol. 1989;42:403-408.
31. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Medical Care. 1989;27:178-189.
32. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1977.
33. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47:81-87.
34. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-415.
35. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD. 2005;2:75-79.
36. Schipper H. Guidelines and caveats for quality of life measurement in clinical practice and research. Oncology (Williston Park). 1990;4:51-57.
37. Kroenke K, Wyrwich KW, Tierney WM, Babu AN, Wolinsky FD. Physicianestimated disease severity in patients with chronic heart or lung disease: a cross-sectional analysis. Health Qual Life Outcomes. 2006;4:60.
38. Puhan MA, Soesilo I, Guyatt GH, Schunemann HJ. Combining scores from different patient reported outcome measures in meta-analyses: when is it justified? Health Qual Life Outcomes. 2006;4:94.
39. Puhan MA, Guyatt G, Goldstein R, et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med. 2007;101:308-316.
40. Jones PW. Health status: what does it mean for payers and patients? Proc Am Thorac Soc. 2006;3:222-226.
41. Rutten-van MM, Roos B, Van Noord JA. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax. 1999;54:995-1003.
42. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793.
43. Duiverman ML, Wempe JB, Bladder G, Kerstjens HA, Wijkstra PJ. Health-related quality of life in COPD patients with chronic respiratory failure. Eur Respir J. 2008;32:379-386.
44. Windisch W, Budweiser S, Heinemann F, Pfeifer M, Rzehak P. The Severe Respiratory Insufficiency Questionnaire was valid for COPD patients with severe chronic respiratory failure. J Clin Epidemiol. 2008;61:848-853.
45. Carone M, Bertolotti G, Anchisi F, Zotti AM, Donner CF, Jones PW. Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group. Eur Respir J. 1999;13:1293-1300.
46. Windisch W, Freidel K, Schucher B, Baumann H, Wiebel M, Matthys H, et al. The Severe Respiratory Insufficiency (SRI) Questionnaire: a specific measure of health-related quality of life in patients receiving home mechanical ventilation. J Clin Epidemiol. 2003;56:752-759.
47. Arnould B. Patient-Reported Outcomes in clinical practice. From measurement instruments to decision tools: much more than a simple change in format. PRO Newsletter. 2006;36:21-24.
48. Marquis P, Arnould B, Acquadro C, Roberts W. Patient-Reported Outcomes and Health-Related Quality of Life in effectiveness studies: pros and cons. Drug Dev Res. 2006;67:193-201.